Long-Term Immunity to Measles after Allogeneic Hematopoietic Cell Transplantation: Factors Associated with Seroprotection before Revaccination.

MLA

Robin, Christine, et al. “Long-Term Immunity to Measles after Allogeneic Hematopoietic Cell Transplantation: Factors Associated with Seroprotection before Revaccination.” Biology of Blood & Marrow Transplantation, vol. 26, no. 5, May 2020, pp. 985–91. EBSCOhost, https://doi.org/10.1016/j.bbmt.2020.02.001.

APA

Robin, C., Mariaggi, A.-A., Redjoul, R., Leclerc, M., Beckerich, F., Cabanne, L., Pautas, C., Maury, S., Rozenberg, F., & Cordonnier, C. (2020). Long-Term Immunity to Measles after Allogeneic Hematopoietic Cell Transplantation: Factors Associated with Seroprotection before Revaccination. Biology of Blood & Marrow Transplantation, 26(5), 985–991. https://doi.org/10.1016/j.bbmt.2020.02.001

Chicago

Robin, Christine, Alice-Andree Mariaggi, Rabah Redjoul, Mathieu Leclerc, Florence Beckerich, Ludovic Cabanne, Cécile Pautas, Sébastien Maury, Flore Rozenberg, and Catherine Cordonnier. 2020. “Long-Term Immunity to Measles after Allogeneic Hematopoietic Cell Transplantation: Factors Associated with Seroprotection before Revaccination.” Biology of Blood & Marrow Transplantation 26 (5): 985–91. doi:10.1016/j.bbmt.2020.02.001.